Apollon Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.16M | Buy |
89,849
+799
| +0.9% | +$37K | 0.08% | 211 |
|
|
2025
Q1 | $5.43M | Buy |
89,050
+3,343
| +4% | +$204K | 0.12% | 160 |
|
|
2024
Q4 | $4.85M | Buy |
85,707
+10,622
| +14% | +$601K | 0.11% | 165 |
|
|
2024
Q3 | $3.88M | Buy |
75,085
+4,321
| +6% | +$224K | 0.11% | 161 |
|
|
2024
Q2 | $2.94M | Sell |
70,764
-9,872
| -12% | -$410K | 0.09% | 208 |
|
|
2024
Q1 | $4.37M | Buy |
80,636
+2,895
| +4% | +$157K | 0.14% | 136 |
|
|
2023
Q4 | $3.99M | Buy |
77,741
+3,525
| +5% | +$181K | 0.14% | 143 |
|
|
2023
Q3 | $4.31M | Sell |
74,216
-4,750
| -6% | -$276K | 0.22% | 86 |
|
|
2023
Q2 | $5.05M | Buy |
78,966
+3,284
| +4% | +$210K | 0.24% | 84 |
|
|
2023
Q1 | $5.25M | Buy |
75,682
+125
| +0.2% | +$8.66K | 0.32% | 64 |
|
|
2022
Q4 | $5.44M | Buy |
75,557
+1,670
| +2% | +$120K | 0.39% | 51 |
|
|
2022
Q3 | $5.25M | Buy |
73,887
+3,619
| +5% | +$257K | 0.43% | 45 |
|
|
2022
Q2 | $5.41M | Buy |
70,268
+4,185
| +6% | +$322K | 0.45% | 40 |
|
|
2022
Q1 | $4.83M | Sell |
66,083
-1,067
| -2% | -$77.9K | 0.34% | 60 |
|
|
2021
Q4 | $4.19M | Buy |
67,150
+29,702
| +79% | +$1.85M | 0.31% | 69 |
|
|
2021
Q3 | $2.22M | Buy |
37,448
+28,366
| +312% | +$1.68M | 0.3% | 67 |
|
|
2021
Q2 | $607K | Sell |
9,082
-1,482
| -14% | -$99.1K | 0.11% | 195 |
|
|
2021
Q1 | $667K | Buy |
+10,564
| New | +$667K | 0.13% | 168 |
|
|
2020
Q4 | – | Sell |
-4,303
| Closed | -$259K | – | 209 |
|
|
2020
Q3 | $259K | Buy |
4,303
+2,563
| +147% | +$154K | 0.12% | 126 |
|
|
2020
Q2 | $102K | Buy |
+1,740
| New | +$102K | 0.06% | 169 |
|